Serine/threonine‐protein kinase PLK‐1, also known as polo‐like kinase 1 (PLK‐1), has been implicated in many different cancers, therefore targeting PLK‐1 represents one of the novel therapeutics for cancer treatment.111, 112. The gene discussed is PLK1; the disease is cancer.